Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ALBIREO PHARMA, INC.
| Metric | ALBIREO PHARMA, INC. Healthcare |
|---|---|
| Quality Score | 42 / 100 |
| Revenue (latest) | $41M |
| Net income (latest) | −$34M |
| Operating margin | −304.3% |
| Net margin | −83.9% |
| Return on equity | −19.4% |
| Return on assets | −11.3% |
| Return on capital (ROCE) | −48.1% |
| Debt / equity | 0.72× |
| Revenue growth (YoY) | 388.4% |
| Altman Z″ (distress) | 0.32 |
| Accruals / assets | 24.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.